Using exome sequencing and rare variant burden testing in a well-curated EOCRC cohort, we confirmed significant enrichment of LoF variants in established tumor suppressor genes and identified MEIKIN as a novel candidate susceptibility gene, with supportive evidence in an independent population dataset for distal colon cancer. This evidence concerns the gene MEIKIN and colonic neoplasm.